Rosti Group, the global plastic injection moulding and contract manufacturing company, has acquired Alvi Group. Alvi’s sites in Norway, Sweden, Poland and China, and about 400 colleagues, are now part of Rosti.
The acquisition took place on 2 November 2026. Financial terms are not disclosed. Rosti now has about 3,000 employees and combined revenue of about EUR 450 million. Norway becomes a new country for Rosti, and the acquisition expands Rosti’s capabilities in Sweden, Poland and China.
Why Rosti is acquiring Alvi Group
The acquisition is a strategic step towards becoming a stronger, more competitive global manufacturing partner, from concept to reality. It
- expands Rosti’s customer base in industrial and medical markets
- widens the manufacturing footprint, with Norway as a new country
- adds capabilities and expertise
- strengthens Rosti’s position in medical device manufacturing
- reinforces Rosti’s commitment to sustainable production, with CSRD-aligned sustainability practices
- The two companies share similar cultures and values.
Jonas Persson, CEO of Rosti Group, says:
“This acquisition strengthens Rosti. We’re gaining proven capabilities and experienced teams in plastics manufacturing, expanding our offer in Sweden, Poland and China, while adding Norway to our footprint. Combined with our existing operations across USA, Europe and Asia, we can now serve our customers even more comprehensively. The integration of Alvi into Rosti Group allows us to leverage our scale and expertise across new and different markets.”